Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018
Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …

News
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018
Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …

News
novartis_outside_1

Novartis debuts new data showing Cosentyx’s superiority over Janssen’s Stelara in psoriasis

January 16, 2018
Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma

Novartis has lifted the curtain on new data comparing the efficacy of Cosentyx (secukinumab) to Janssen’s Stelara (ustekinumab) in achieving …

News
barrett_novartis

Novartis prises Pfizer’s Oncology Head away

January 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

Appointment
Novartis image

Novartis’ Kisqali gains breakthrough status in premenopausal breast cancer

January 3, 2018
Research and Development, Sales and Marketing Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough …

News

Novartis hit by court loss, could spur numerous cases across industry

December 22, 2017
Medical Communications, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held …

News

NICE recommends Novartis’ Extavia for MS, but knocks back a raft of other beta interferons

December 20, 2017
Research and Development, Sales and Marketing Extavia, MS, NICE, Novartis, beta interferon, multiple sclerosis

NICE has revealed that it has passed draft guidance that recommends Novartis’ Extavia (interferon beta 1b) for the treatment of …

News
novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017
Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …

News
tesaro

New PARP inhibitor hits UK market, offering distinct advantage

December 18, 2017
Sales and Marketing AstraZeneca, Novartis, Tesaro, Zejula, biotech, drugs, lynparza, pharma, pharmaceutical

Tesaro’s Zejula has been launched in the UK but availability on the NHS has still not been decided. The PARP …

News
bruno-strigini-image

Novartis’ President of Oncology announces retirement

December 15, 2017
Medical Communications Bruno Strigini, Novartis, pharma

Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons …

News
shutterstock_138095450

Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …

News
novartislr

Novartis Kisqali improves PFS in younger women

December 7, 2017
Research and Development Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

A Phase 3 trial looking at the use of Kisqali (ribociclib) to treat premenopausal or perimenopausal women with hormone-receptor positive, …

News
news_accc

Two big pharma companies accused of false marketing

December 6, 2017
Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …

News
novartis_window

Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no

December 6, 2017
Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

News
novartis_outside_1

Novartis reveals strong long-term data Cosentyx in psoriasis of the hands and feet

December 1, 2017
Medical Communications, Research and Development Cosentyx, Novartis, palmoplantar psoriasis, pharma, psoriasis

Novartis has released new data for Consentyx (secukinumab) which it claims make the IL-17A inhibitor “the first biologic to show …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026